Cytokines are not a requisite part of the pathophysiology leading to cardiac decompensation

F A Recchia1, R D Bernstein, P B Sehgal

  • 1Department of Physiology, New York Medical College, Valhalla, New York, 10595, USA.

Insights

This study found that key inflammatory cytokines, tumor necrosis factor-alpha and interleukin-6, did not increase in dogs with pacing-induced heart failure. These findings suggest cytokines are not universally involved in cardiac dysfunction pathogenesis.

Area of Science:

  • Cardiology
  • Immunology
  • Pathophysiology

Background:

  • Proinflammatory cytokines like TNF-alpha and IL-6 are hypothesized to contribute to cardiac injury in chronic heart failure.
  • Investigating cytokine levels during heart failure progression is crucial for understanding disease mechanisms.

Purpose of the Study:

  • To determine if plasma levels of tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) increase during pacing-induced heart failure in a canine model.
  • To assess the release of these cytokines from the heart into the coronary sinus during heart failure development.

Main Methods:

  • Seven dogs underwent cardiac pacing (210 bpm for 3 weeks, then 240 bpm for 1 week) to induce decompensated heart failure.
  • Hemodynamic measurements and blood samples from the aorta and coronary sinus were collected at baseline, 3 weeks, and end-stage failure.
  • Plasma concentrations of IL-6 and TNF-alpha were quantified using standard assays.

Main Results:

  • Pacing successfully induced decompensated heart failure, evidenced by increased left ventricular end-diastolic pressure and decreased dP/dtmax.
  • Arterial and coronary sinus concentrations of IL-6 did not significantly change from control to end-stage failure.
  • TNF-alpha remained undetectable in arterial and coronary sinus blood throughout the study.

Conclusions:

  • Circulating levels of IL-6 and TNF-alpha do not increase during the development of pacing-induced heart failure in this canine model.
  • The heart does not appear to release these cytokines into the coronary sinus during heart failure.
  • These findings challenge the universal role of TNF-alpha and IL-6 in the pathogenesis of all forms of cardiac dysfunction.

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...